These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 2523955)

  • 21. Experimental cutaneous leishmaniasis: disseminated leishmaniasis in genetically susceptible and resistant mice.
    Scott PA; Farrell JP
    Am J Trop Med Hyg; 1982 Mar; 31(2):230-8. PubMed ID: 6462064
    [No Abstract]   [Full Text] [Related]  

  • 22. Cutaneous leishmaniasis in anti-IgM-treated mice: enhanced resistance due to functional depletion of a B cell-dependent T cell involved in the suppressor pathway.
    Sacks DL; Scott PA; Asofsky R; Sher FA
    J Immunol; 1984 Apr; 132(4):2072-7. PubMed ID: 6230400
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cure of progressive murine leishmaniasis: interleukin 4 dominance is abolished by transient CD4(+) T cell depletion and T helper cell type 1-selective cytokine therapy.
    Heinzel FP; Rerko RM
    J Exp Med; 1999 Jun; 189(12):1895-906. PubMed ID: 10377185
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Murine cutaneous leishmaniasis: resistance in reconstituted nude mice and several F1 hybrids infected with Leishmania tropica major.
    Mitchell GF
    J Immunogenet; 1983 Oct; 10(5):395-412. PubMed ID: 6606002
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The induction of a protective response in Leishmania major-infected BALB/c mice with anti-CD40 mAb.
    Ferlin WG; von der Weid T; Cottrez F; Ferrick DA; Coffman RL; Howard MC
    Eur J Immunol; 1998 Feb; 28(2):525-31. PubMed ID: 9521062
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exacerbation of murine cutaneous leishmaniasis by adoptive transfer of parasite-specific helper T cell populations capable of mediating Leishmania major-specific delayed-type hypersensitivity.
    Titus RG; Lima GC; Engers HD; Louis JA
    J Immunol; 1984 Sep; 133(3):1594-600. PubMed ID: 6205088
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vaccination against cutaneous leishmaniasis in a murine model. I. Induction of protective immunity with a soluble extract of promastigotes.
    Scott P; Pearce E; Natovitz P; Sher A
    J Immunol; 1987 Jul; 139(1):221-7. PubMed ID: 3495599
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunologically mediated regression of a murine lymphoma after treatment with anti-L3T4 antibody. A consequence of removing L3T4+ suppressor T cells from a host generating predominantly Lyt-2+ T cell-mediated immunity.
    Awwad M; North RJ
    J Exp Med; 1988 Dec; 168(6):2193-206. PubMed ID: 2974065
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetically resistant mice lacking interleukin-12 are susceptible to infection with Leishmania major and mount a polarized Th2 cell response.
    Mattner F; Magram J; Ferrante J; Launois P; Di Padova K; Behin R; Gately MK; Louis JA; Alber G
    Eur J Immunol; 1996 Jul; 26(7):1553-9. PubMed ID: 8766560
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Leishmania major: analysis of lymphocyte and macrophage cellular phenotypes during infection of susceptible and resistant mice.
    Heinzel FP; Sadick MD; Locksley RM
    Exp Parasitol; 1988 Apr; 65(2):258-68. PubMed ID: 3127233
    [TBL] [Abstract][Full Text] [Related]  

  • 31. T cell-induced Ig allotypic suppression in mice. II. Both CD4+ CD8- and CD4- CD8+ T cell subsets from sensitized Igha mice are required to induce suppression of Igh-1b allotype expression.
    Benaroch P; Bordenave G
    J Immunol; 1989 Jan; 142(1):1-7. PubMed ID: 2521230
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CD4-CD8- T cell receptor alpha beta T cells: generation of an in vitro major histocompatibility complex class I specific cytotoxic T lymphocyte response and allogeneic tumor rejection.
    Mieno M; Suto R; Obata Y; Udono H; Takahashi T; Shiku H; Nakayama E
    J Exp Med; 1991 Jul; 174(1):193-201. PubMed ID: 1905338
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intrapulmonary growth and dissemination of an avirulent strain of Cryptococcus neoformans in mice depleted of CD4+ or CD8+ T cells.
    Hill JO; Harmsen AG
    J Exp Med; 1991 Mar; 173(3):755-8. PubMed ID: 1900084
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Host and parasite factors influencing the expression of cutaneous leishmaniasis.
    Sher A; Sacks DL; Scott PA
    Ciba Found Symp; 1983; 99():174-89. PubMed ID: 6227463
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Leishmania major: nature of immunity induced by immunization with a mutagenized avirulent clone of the parasite in mice.
    McGurn M; Boon T; Louis JA; Titus RG
    Exp Parasitol; 1990 Jul; 71(1):81-9. PubMed ID: 1972362
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The cellular immune response to a purified antigen from Leishmania mexicana subsp. amazonensis enhances the size of the leishmanial lesion on susceptible mice.
    Rodrigues MM; Mendonça-Previato L; Charlab R; Barcinski MA
    Infect Immun; 1987 Dec; 55(12):3142-8. PubMed ID: 3500131
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CD8 cells play a critical role in delayed type hypersensitivity to intact Cryptococcus neoformans.
    Mody CH; Paine R; Jackson C; Chen GH; Toews GB
    J Immunol; 1994 Apr; 152(8):3970-9. PubMed ID: 8144964
    [TBL] [Abstract][Full Text] [Related]  

  • 38. T cell response in murine Leishmania mexicana amazonensis infection: production of interferon-gamma by CD8+ cells.
    Chan MM
    Eur J Immunol; 1993 May; 23(5):1181-4. PubMed ID: 8097471
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of systemic protection and delayed-type hypersensitivity to Listeria monocytogenes is mediated by different T-cell subsets.
    Baldridge JR; Barry RA; Hinrichs DJ
    Infect Immun; 1990 Mar; 58(3):654-8. PubMed ID: 2106491
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunoregulatory function of CD3+, CD4-, and CD8- T cells. Gamma delta T cell receptor-positive T cells from nude mice abrogate oral tolerance.
    Fujihashi K; Kiyono H; Aicher WK; Green DR; Singh B; Eldridge JH; McGhee JR
    J Immunol; 1989 Dec; 143(11):3415-22. PubMed ID: 2573632
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.